Modulating proinflammatory processes using tocilizumab in major depressive disorder
Latest Information Update: 23 Dec 2019
At a glance
- Drugs Tocilizumab (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 21 Jun 2018 New trial record